Align Sugar-binding transport ATP-binding protein aka MalK1 aka TT_C0211, component of The trehalose/maltose/sucrose/palatinose porter (TTC1627-9) plus MalK1 (ABC protein, shared with 3.A.1.1.24) (Silva et al. 2005; Chevance et al., 2006). The receptor (TTC1627) binds disaccharide alpha-glycosides, namely trehalose (alpha-1,1), sucrose (alpha-1,2), maltose (alpha-1,4), palatinose (alpha-1,6) and glucose (characterized)
to candidate WP_022529099.1 L248_RS05360 ABC transporter ATP-binding protein
Query= TCDB::Q72L52 (376 letters) >NCBI__GCF_000469325.1:WP_022529099.1 Length = 376 Score = 271 bits (694), Expect = 2e-77 Identities = 162/377 (42%), Positives = 220/377 (58%), Gaps = 14/377 (3%) Query: 4 VRLEHVWKRFGKVVAVKDFNLETEDGEFVVFVGPSGCGKTTTLRMIAGLEEISEGNIYIG 63 ++L+H+ K+FG + + + ++GEF V VGPSG GK+T LR+IAGL S G+++ Sbjct: 3 IKLDHLTKQFGDTAVLDGISAQIQEGEFFVLVGPSGSGKSTLLRIIAGLIPASSGSVFFD 62 Query: 64 DRLVNDVPPKDRDIAMVFQNYALYPHMNVYENMAFGLRLRRYPKDEIDRRVKEAARILKI 123 + V D+PPKDR + MVFQNYAL P M+V +N+ FGL E +RV +A ++ + Sbjct: 63 SQNVTDLPPKDRHLTMVFQNYALLPFMSVADNIRFGLHNLDLDATEEAKRVNDALDMVHL 122 Query: 124 EHLLNRKPRELSGGQRQRVAMGRAIVREPKVFLMDEPLSNLDAKLRVEMRAEIAKLQRRL 183 L +RKP+ELSGGQ+QRVA+ RAI + + LMDEPLSNLDA+LR EMR E+ +L + L Sbjct: 123 TELRDRKPKELSGGQQQRVALARAIATKASLVLMDEPLSNLDAQLRTEMRQELVQLHKEL 182 Query: 184 GVTTIYVTHDQVEAMTLGHRIVVMKDGEIQQVDTPLNLYDFPANRFVAGFIGSPSMNFVR 243 G+T +YVTHDQVEAMT+G RI+V+ D IQQV TPL+LY+ PAN+FVA FIGSP MN Sbjct: 183 GMTLLYVTHDQVEAMTMGERIMVLNDHHIQQVGTPLDLYNHPANKFVATFIGSPKMNMFD 242 Query: 244 AGVEVQGEKVYLVAPGFRIRANAVLGSALKPY--AGKEVWLGVRPEHLGLKGYTTIPEEE 301 A V+ L AN PY A LG+RPE + L + Sbjct: 243 ATVDALEHFATLELTD----ANQHSVRLPLPYDLAAGAYQLGIRPEKITLSRSAS----A 294 Query: 302 NVLRGEVEVVEPLGAETEIHVAVNGTLLVAKVDGHAPVKPGDKV--ELLADTQRLHAFDL 359 V V LG E+ + + NG +A V PV V L D LH FD Sbjct: 295 GSFPVRVMAVANLGRESSVSLVNNGHEFIASVPEQYPVPENQIVYATLPTDAADLHFFDE 354 Query: 360 ETDRTIGH--AQERAAV 374 +++ + + E+A V Sbjct: 355 KSNLAVNNKGVPEKAGV 371 Lambda K H 0.320 0.139 0.400 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 328 Number of extensions: 14 Number of successful extensions: 1 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 376 Length of database: 376 Length adjustment: 30 Effective length of query: 346 Effective length of database: 346 Effective search space: 119716 Effective search space used: 119716 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 50 (23.9 bits)
This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory